Table 3.
The association between risk factors and the odds of being prescribed a second course of budesonide.
| A second course of budesonide | Adjusted odds ratio (95% confidence interval) | ||
|---|---|---|---|
| Yes (n = 90) | No (n = 48) | ||
| Age at diagnosis, years (SD) | 61.0 (13.3) | 66.1 (12.1) | 0.97 (0.93–0.99) |
| Female gender, % | 79 | 77 | 1.06 (0.43–2.58) |
| Body mass index >30 kg/m2, % | 14 | 21 | 0.69 (0.26–1.83) |
| Smoker at diagnosis, % | 18 | 15 | 1.06 (0.37–3.1) |
| ASA a , % | 16 | 21 | 0.99 (0.39–2.90) |
| NSAIDs a , % | 21 | 8 | 3.70 (1.06–12.9) |
| PPIs a , % | 36 | 31 | 1.09 (0.45–2.63) |
| Serotonin reuptake inhibitors a , % | 21 | 12 | 2.07 (0.71–6.04) |
| Statins a , % | 30 | 33 | 0.83 (0.35–1.99) |
a
Prescribed within 1 year before the second course of budesonide or the end of observation.
ASA, acetylsalicylic acid; NSAID, non-steroidal anti-inflammatory drug; PPI, proton pump inhibitor; SD, standard deviation.